Another study, by Feldheim et al. [33], quantified ATF5 mRNA in a number of low-grade astrocytoma (WHO grade II) and GBM tumors as well as in normal brain. This evidence concerns the gene ATF5 and astrocytoma (excluding glioblastoma).